Has Christina Dueno received payments from drug or device companies?

Yes. Drug and device makers reported $5,079 in general payments to Christina Dueno across 195 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christina Dueno did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christina Dueno come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christina Dueno

Psychiatric/Mental Health · Moraine, OHNPI 1568813947

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,906 of the $5,079 with a category attached, or 76.9%. 21 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 25.1% of the total. Reporting peaked in 2024 at $2,027 and has fallen 89.2% since, to $219 in 2025. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,079in general payments, 2019–2025

Across 195 payments — averaging $26.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Scientific Affairs, LLC$1K
Johnson & Johnson$713
Axsome Therapeutics, Inc.$639
Sunovion Pharmaceuticals Inc.$510
Alkermes, Inc.$451
Otsuka America Pharmaceutical, Inc.$333
plus $1K from 15 others

What the payments were for

Consulting fees$1,17323%
Food & beverage$3,90677%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Scientific Affairs, LLC	2	$1,276
Johnson & Johnson	20	$713
Axsome Therapeutics, Inc.	25	$639
Sunovion Pharmaceuticals Inc.	29	$510
Alkermes, Inc.	36	$451
Otsuka America Pharmaceutical, Inc.	19	$333
Lundbeck LLC	15	$234
AbbVie	8	$200
Takeda Pharmaceuticals U.S.A., Inc.	8	$142
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$132
Tris Pharma Inc	5	$94
Teva Pharmaceuticals USA, Inc.	4	$76
E.r. Squibb & Sons, L.L.C.	4	$65
Supernus Pharmaceuticals, Inc.	4	$62
Indivior Inc.	2	$40
Neurocrine Biosciences, Inc.	2	$33
Vanda Pharmaceuticals Inc.	1	$20
Avanir Pharmaceuticals, Inc.	1	$16
Jazz Pharmaceuticals Inc.	1	$15
Eisai Inc.	1	$14
Idorsia Pharmaceuticals US Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,079 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
SpravatoEsketamine Hcl	317	$508,263
Invega SustennaPaliperidone Palmitate	21	$69,207
CaplytaLumateperone Tosylate	27	$44,737
AuvelityDextromethorphan Hbr/Bupropion	24	$21,108
QuviviqDaridorexant Hcl	23	$11,257
Lurasidone Hcl	24	$9,736
TrintellixVortioxetine Hydrobromide	15	$9,098
Quetiapine Fumarate ErQuetiapine Fumarate	27	$2,631
Aripiprazole	12	$2,329
Duloxetine Hcl	44	$1,167
Clozapine	18	$1,132
Divalproex Sodium ErDivalproex Sodium	28	$1,052
Memantine Hcl	18	$1,041
Buspirone Hcl	74	$975
Prazosin Hcl	32	$939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonSpravato, Invega Sustenna	$713	$577,470338 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$132	$44,73727 claims
Axsome Therapeutics, Inc.Auvelity	$639	$21,10824 claims
Idorsia Pharmaceuticals US IncQuviviq	$14	$11,25723 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$142	$9,09815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Moraine

Tamara ThornMoraine$89K
Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →